Morepen Laboratories Ltd
Morepen Labs. | 500288
MOREPENLAB - Share Price Chart
Stock Performance
Ratios
About Company
- Morepen Laboratories Limited is an India-based pharmaceutical company
- Its products include Loratadine, Montelukast Sodium, Atorvastatin Calcium and Sultamicillin
- The company markets formulation products in various therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesic, antiallergic and neuropsychiatry with brands, such as Saltum, Saltumax, Cefpopen, Cefpen-S, Dom-DT, Acifix, Rabipen- DSR and Montelast
- The new products added to the therapeutic categories, include Kilbac, Ducal D, Aclomore and Montelast-L
- The company has three state-of-the-art manufacturing plants in the northern state of Himachal Pradesh (HP) in India
- The main plant at Parwanoo is inspected and approved by United States Food and Drug Administration (USFDA) for production of Loratadine, which is the best selling anti-allergy drug globally
- The company has developed a hi-tech Pharma complex at Morepen Village, Baddi (HP) on 60 acres of land that has various multipurpose pharma facilities for API & finished dosages and a Research Centre
- Morepen Laboratories Limited was established in 1984
- The company has filed 14 patents including 6 international PCT applications
- The company has filed an international patent on a new amorphous form of the cholesterol-reducing drug Lipitor (Atorvastatin) that is the largest selling drug in the world
Ethics: Morepen Laboratories Ltd is flagged for
Adequate
The company demonstrates adequate ESG practices with room for improvement.
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Top Losers
Group Stocks
Frequently Asked Questions
What is Share Price of Morepen Laboratories Ltd?
The current share price of Morepen Laboratories Ltd (Morepen Labs.) is ₹136.55. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Morepen Laboratories Ltd?
The Price-to-Earnings (P/E) ratio of Morepen Laboratories Ltd is 68.64. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Morepen Laboratories Ltd?
Morepen Laboratories Ltd has a 52-week high of ₹150.70 and a 52-week low of ₹33.05. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Morepen Laboratories Ltd?
Morepen Laboratories Ltd offers a dividend yield of 0.14%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Morepen Laboratories Ltd?
The Earnings Per Share (EPS) of Morepen Laboratories Ltd is ₹2.14. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Morepen Laboratories Ltd?
Morepen Laboratories Ltd has a Return on Equity (ROE) of 5.45%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
